01 June 2022 | News
The funds raised will be deployed towards deeper investment in product development as well as technology across systems
Image Credit: Shutterstock
Health-tech start-up Orange Health has raised $25 million in Series B funding round, led by Bertelsmann India Investments and co-led by General Catalyst. The round witnessed the participation of existing investors like Accel, Y Combinator, Good Capital and Uncorrelated Ventures.
The funds raised will be deployed towards deeper investment in product development as well as technology across systems, user experience and building world-class laboratories. The company also plans to expand to new markets and strengthen its teams across all functions. The company has previously raised $10 million, with its series A being led by Accel in 2021.